[1] |
Roth GA,Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study[J]. J Am Coll Cardiol, 2020, 76(25): 2982-3021.
|
[2] |
Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence,awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7): 535-541.
|
[3] |
中华医学会心血管病学分会, 中国生物医学工程学会心律学分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6): 572-618.
|
[4] |
Blomström-Lundqvist C, Gizurarson S, Schwieler J, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation:the CAPTAF randomized clinical trial[J]. JAMA, 2019, 321(11): 1059-1068.
|
[5] |
Mark DB, Anstrom KJ, Sheng S, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial[J]. JAMA, 2019, 321(13): 1275-1285.
|
[6] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志, 2022, 26(1): 15-88.
|
[7] |
van der Endt VHW, Milders J, Penning de Vries BBL, et al. Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation[J]. Europace, 2022, 24(11): 1739-1753.
|
[8] |
Choi SY, Kim MH, Lee KM, et al. Age-dependent anticoagulant therapy for atrial fibrillation patients with intermediate risk of ischemic stroke: a nationwide population-based study[J]. Thromb Haemost, 2021, 121(9): 1151-1160.
|
[9] |
Friberg L, Skeppholm M, Terént A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1[J]. J Am Coll Cardiol, 2015, 65(3): 225-232.
|
[10] |
Pisters R, Lane DA, Nieuwlaat R, et al. A novel user friendly score (HAS BLED) to assess 1 year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey[J]. Chest, 2010, 138(5): 1093-1100.
|
[11] |
Gorog DA, Gue YX, Chao TF, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: a position paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society[J]. Europace, 2022, 24(11): 1844-1871.
|
[12] |
Fabritz L, Crijns H, Guasch E, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA consensus conference[J]. Europace, 2021, 23(3): 329-344.
|
[13] |
Chao TF, Chan YH, Tuan TC, et al. Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study[J]. Eur Heart J Qual Care Clin Outcomes, 2022, 8(5): 588-595.
|
[14] |
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498.
|
[15] |
Steffel J. Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures[J]. Eur Heart J Suppl, 2020, 22 (Suppl Ⅰ): I32-I37.
|
[16] |
Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice[J]. J Infus Nurs, 2021, 44 (supplⅠ): S1-S224.
|
[17] |
王莉, 潘文龙. 一体化护理管理模式在放射科护理工作中的应用效果分析[J]. 中华介入放射学电子杂志, 2019, 7(1): 81-84.
|
[18] |
陈凌, 杨满青, 林丽霞. 心血管疾病临床护理[M]. 广州: 广东科技出版社, 2021: 45.
|
[19] |
NICE guideline. Atrial fibrillation: diagnosis and management[EB/OL]. [2021-06-30].
URL
|
[20] |
Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Europace, 2021, 23(10): 1612-1676.
|
[21] |
中国湖北绿色电生理联盟, 武汉医学会心电生理与起搏学分会. 心房颤动导管射频消融围手术期管理要点和认识[J]. 临床内科杂志, 2020, 37(10): 743-746.
|